EDN1 and cancer: Elevated plasma ET-1 level is also observed in patients of diabetes mellitus [9] and cardiovascular diseases [11] while ET-1 has been suggested to be related to the promotion of cancer development by modulating mitosis, angiogenesis and apoptosis [13].